Document is current
Any future updates will be listed below
-
Authors
Campanelli, Anastasia
Métais, Alice
Bouchoucha, Yassine
Beccaria, Kevin
Laprie, Anne
Blauwblomme, Thomas
Guida, Lelio
Benichi, Sandro
Dufour, Christelle
Guerrini-Rousseau, Lea
Simbozel, Marie
Tauziede-Espariat, Arnault
Varlet, Pascale
Sellami, Noura
Bolle, Stephanie
Martin, Valentine
Boddaert, Nathalie
Appay, Romain
Dangouloff-Ros, Volodia
Khouri, Céline
Bourdeaut, Franck
Doz, François
Grill, Jacques
Abbou, Samuel
- License Information
-
More Information
Article History
Received: 5 May 2025
Accepted: 11 August 2025
First Online: 1 October 2025
Declarations
:
: Parents or guardians gave consent for a retrospective analysis according to the institutional review board of Gustave Roussy (IRB: N° 2024 − 446).
: Not applicable.
: S.A.: FORE pharmaceutical, Lilly and Ipsen: research funding support as a consultant. Patent for oral suspension of temozolomide. Y.B.: Institut ServierOther authors declare no competing interests.
